HHS Recommends Rescheduling Marijuana to Schedule III

Key Takeaway

The US Department of Health and Human Services formally recommended that the DEA move marijuana from Schedule I to Schedule III of the Controlled Substances Act, marking the most consequential federal cannabis policy development in 50 years. HHS cited cannabis's accepted medical use and lower abuse potential compared to Schedule I substances as justification for the reclassification. The recommendation noted that over 30,000 healthcare practitioners across 43 jurisdictions authorize cannabis for more than 6 million registered patients under state medical programs. Schedule III reclassification would eliminate Section 280E tax exposure for state-legal cannabis businesses. For cannabis operators, the HHS recommendation was the federal breakthrough the industry had awaited for a decade.